MedeliX
Start asking

Propranolol

Inderal · ATC code C07AA05

Also known as: Propranololo · Brand names: Hemangeol, Inderal LA, Inderal XL, Dociton, Obsidan, Propra, Propranolol Al, Propranolol Ct Abz Pharma, Propranolol Ipca, Propranolol Puren, Propranolol Stada, Inderal, Dideral, Hemangiol

Key facts
Active substance
Propranolol
Drug class
Beta blocker
ATC code
C07AA05
Authorisation
authorised nationally; no central EU authorisation
Information as of
2026-10-27

Key facts

Propranolol is a nonselective beta-blocker. Per the US label it is used for hypertension, angina, atrial fibrillation, after myocardial infarction, migraine prophylaxis and essential tremor, among others.

What it is used for

  • Hypertension (not for hypertensive emergencies)
  • Angina pectoris due to coronary atherosclerosis
  • Ventricular rate control in atrial fibrillation
  • Reducing cardiovascular mortality after the acute phase of myocardial infarction
  • Migraine prophylaxis (not for treating an attack)
  • Essential tremor, hypertrophic subaortic stenosis, pheochromocytoma (adjunct to alpha-blockade)

Dosing

  • Hypertension: start 40 mg twice daily; usual maintenance 120 mg to 240 mg per day
  • Angina: 80 mg to 320 mg daily, divided two to four times a day
  • Atrial fibrillation: 10 mg to 30 mg three or four times daily
  • After myocardial infarction: 180 mg to 240 mg per day in divided doses
  • Migraine: start 80 mg daily, usual 160 mg to 240 mg per day; stop if no response four to six weeks after reaching the maximum dose
  • Essential tremor: start 40 mg twice daily, usually 120 mg per day

Contraindications

  • Cardiogenic shock
  • Sinus bradycardia and heart block greater than first degree
  • Bronchial asthma
  • Known hypersensitivity to propranolol

Important warnings

  • Abrupt discontinuation can worsen angina and cause myocardial infarction; taper over at least a few weeks
  • Hypersensitivity and serious skin reactions (e.g. Stevens-Johnson syndrome)
  • Cardiac failure
  • May mask signs of hypoglycemia; hypoglycemia reported after exertion or with renal insufficiency
  • May mask signs of hyperthyroidism

Side effects

  • Cardiovascular: bradycardia, congestive heart failure, AV block, hypotension, Raynaud-type arterial insufficiency
  • CNS: lightheadedness, depression, fatigue, vivid dreams, hallucinations
  • Gastrointestinal: nausea, vomiting, diarrhea, constipation
  • Bronchospasm, agranulocytosis, hypersensitivity reactions

Interactions

  • Drugs affecting CYP2D6, 1A2 or 2C19 may change efficacy and toxicity
  • Antiarrhythmics: propafenone and amiodarone additive; quinidine raises propranolol levels
  • Lidocaine: reduced clearance, toxicity reported

Pregnancy and breastfeeding

  • Embryotoxicity in animal studies at high doses
  • Propranolol is excreted in human milk; caution when nursing

Summary of the official product information, written with AI on 2026-10-28. Every number was checked automatically against the original text. Not reviewed by a physician – the full official text is authoritative.

Full official text →

Common questions – ask Medelix

For patients

Patient information (US)

This product has no separate US patient information.

Authorisation and brand names by country

Medicines with exactly this active-substance composition, as listed in the national registers – alphabetical and without ranking. Whether a product is currently available is not shown here.

USA

  • HemangeolPierre Fabre Pharmaceuticals, Inc. · 1 register entry
  • Inderal LAANI Pharmaceuticals, Inc. · 1 register entry
  • Inderal XLANI Pharmaceuticals, Inc. · 1 register entry

Source: U.S. FDA – Drug labels (openFDA/DailyMed), as of 2026-10-28

Germany

  • DocitonMibe Gmbh Arzneimittel · 2 register entries
  • ObsidanPuren Pharma Gmbh & Co. Kg · 1 register entry
  • PropraRatiopharm Gmbh · 2 register entries
  • Propranolol AlAliud Pharma Gmbh · 1 register entry
  • Propranolol Ct Abz PharmaAbz-Pharma Gmbh · 1 register entry
  • Propranolol IpcaIpca Productos Farmaceuticos Unipessoal Lda · 1 register entry
  • Propranolol PurenPuren Pharma Gmbh & Co. Kg · 1 register entry
  • Propranolol StadaStadapharm Gmbh · 1 register entry

Source: EMA – Article 57 product data (EU/EEA), as of 2026-10-28

Austria

  • InderalAtnahs Pharma Netherlands B.V. · 1 register entry

Source: EMA – Article 57 product data (EU/EEA), as of 2026-10-28

Turkey

  • DideralBMED İLAÇ DANIŞMANLIK SAĞLIK ÜRÜN VE HİZMETLERİ TİC. LTD. ŞTİ. · 2 register entries
  • HemangiolPIERRE FABRE DERMO KOZMETİK LTD. ŞTİ. · 1 register entry

Source: TİTCK – Ruhsatlı Beşeri Tıbbi Ürünler Listesi, as of 2026-10-16

Brand names in 25 more European countries
Belgium
Inderal, Propranolol Eg, Propranolol Retard Eg, Propranolol Retard Teva
Bulgaria
Пропранолол Актавис
Croatia
Propranolol Sandoz
Cyprus
Emforal
Denmark
Propal Retard, Propranolol Eql Pharma, Propranolol Medical Valley
Estonia
Propra, Propranolol Accord
Finland
Propral, Propranolol Accord, Ranoprin
France
Avlocardyl, Karnodyl, Propranolol Accord, Propranolol Acetlab, Propranolol Arrow, Propranolol Biogaran, Propranolol Eg, Propranolol Teva
Greece
Inderal
Hungary
Huma-Pronol
Iceland
Hemangiol
Ireland
Beta-Prograne, Half Beta-Prograne, Propranolol Azure
Italy
Inderal
Latvia
Anaprilīns
Liechtenstein
Hemangiol
Luxembourg
Inderal, Propranolol Eg, Propranolol Retard Eg
Malta
Emforal, Propranolol Thame
Netherlands
Propranolol Hcl Accord, Propranolol Hcl Amarox, Propranolol Hcl Cf, Propranolol Hcl Retard Teva, Propranolol Hcl Teva, Propranolol Hydrochloride Aurobindo
Norway
Hemangiol, Propranolol Accord
Poland
Propranolol Accord, Propranolol Aurovitas, Propranolol Wzf
Portugal
Inderal, Propranolol Accord, Propranolol Generis, Propranolol Ipca
Romania
Propranolol
Slovenia
Propranolol Lek
Spain
Propranolol Accord, Propranolol Aurovitas, Propranolol Kern Pharma, Propranolol Tarbis, Sumial
Sweden
Inderal, Propranolol Accord, Propranolol Eql, Propranolol Medical Valley

EMA – Article 57 product data (EU/EEA), 2026-10-28

Medelix receives no money from pharmaceutical companies. Brand names are listed alphabetically and without ranking.

Other substances in the same group

Another question about this substance?

Medelix answers clinical questions from guidelines, studies and product information – every claim with its source.

Sources

  1. U.S. Food and Drug Administration. Propranolol Hydrochloride (Ipca Laboratories Limited) – Prescribing Information, 2025-12-17. DailyMed (NLM), 2026-10-27. https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=9288191e-4d07-4e37-ab66-7b9de9321cf3
  2. U.S. FDA – Drug labels (openFDA/DailyMed), 2026-10-28. https://dailymed.nlm.nih.gov/dailymed/
  3. EMA – Article 57 product data (EU/EEA), 2026-10-28. https://www.ema.europa.eu/en/human-regulatory-overview/post-authorisation/data-medicines-iso-idmp-standards-post-authorisation/public-data-article-57-database
  4. EMA – Article 57 product data (EU/EEA), 2026-10-28. https://www.ema.europa.eu/en/human-regulatory-overview/post-authorisation/data-medicines-iso-idmp-standards-post-authorisation/public-data-article-57-database
  5. TİTCK – Ruhsatlı Beşeri Tıbbi Ürünler Listesi, 2026-10-16. https://www.titck.gov.tr/dinamikmodul/85
  6. Wikidata (CC0): ATC C07AA.

Editorial: Medelix editorial team · last updated 2026-10-27 · How these pages are made · Report an error

Source: U.S. Food and Drug Administration (FDA), prescribing information, via DailyMed (NLM); public domain. Not advertising, not a treatment recommendation. For questions about your own treatment, ask your doctor or pharmacist.